Drug factory · FDA FEI 3002806657

Solvias France

RUE DU CANAL D ALSACE ZONE INDUSTRIELLE, Hombourg, France

France: 1

Problems found, fixed voluntarily at FDA's last inspection, Sep 23, 2022.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

3 drug inspections on record since 2014: 1 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
SelexipagTests it Actelion Pharmaceuticals US, Inc. 66215-718
Vestronidase AlfaTests it Ultragenyx Pharmaceutical Inc. 69794-001

FDA inspection history

EndedResultProgramProblems noted
Sep 23, 2022Problems found, fixed voluntarilyDrug Quality Assurance—
Jul 28, 2017Problems found, fixed voluntarilyDrug Quality Assurance—
Mar 27, 2014No problems foundDrug Quality Assurance—

Registered with FDA for: analysis.